<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158006">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01815593</url>
  </required_header>
  <id_info>
    <org_study_id>NSFC-30872571</org_study_id>
    <nct_id>NCT01815593</nct_id>
  </id_info>
  <brief_title>The Value of Enhanced External Counterpulsation Treatment to Erectile Dysfunction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>China: Ministry of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Enhanced External counterpulsation
      treatment can improve erectile function
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Erectile function evaluated by International Index of Erectile Function-5  questionnaire</measure>
    <time_frame>four weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>endothelial function</measure>
    <time_frame>four weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Flow-mediated dilation：In this method,brachial artery diameter is measured before and after an increase in shear stress that is induced by reactive hyperemia (FMD). Endothelial progenitor cells：Flow cytometry to detect changes in the number of endothelial progenitor cells</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>erectile dysfunction group</arm_group_label>
    <description>Men with erectile dysfunction included for evaluating the erectile function before and after Enhanced external counterpulsation treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Enhanced external counterpulsation(EECP)</intervention_name>
    <description>Enhanced external counterpulsation is mainly used in Cardiovascular and cerebrovascular diseases,which can improve the microcirculation.</description>
    <arm_group_label>erectile dysfunction group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Men with erectile dysfunction in GuangDong province
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. men over 18 years old;

          2. provide signed informed consent;

          3. existence of erectile dysfunction

          4. Agree not to use any other erectile dysfunction treatment at least one month;

        Exclusion Criteria:

          1. a history of long drug abuse;

          2. pelvic, spine, brain trauma or surgery;

          3. endocrine, liver, lung, kidney disease, malignancies, hematological  disorders;

          4. abnormal urogenital status, such as small testicle (&lt;2cm), penile plaques;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>First Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>El-Sakka A, Morsy A, Fagih B. Enhanced external counterpulsation in patients with coronary artery disease-associated erectile dysfunction. Part I: effects of risk factors. J Sex Med. 2007 May;4(3):771-9. Epub 2007 Apr 13.</citation>
    <PMID>17433083</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 21, 2013</lastchanged_date>
  <firstreceived_date>March 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Chen Sheng Fu,MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
